Managed Care
Disease
Management

Looking for Predictive Factors in Advanced Breast Cancer: BOLERO-2, Phase 3

Hope Rugo, MD, discusses the direction of current research into biologic agents for the treatment of advanced breast cancer at the American Society of Clinical Oncology meeting June 3, 2013, in Chicago.